Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam for Agitation Postnasal Surgery
NCT05165914Completed
- Sponsor
- Royal Medical Services
- Start
- May 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in psychomotor agitation comparing Midazolam group with Placebo group (2 arms). Primary endpoint: Development of agitation (RASS score +2 or more) at 1 hour. Started May 2021; status: completed.
02
Drugs
midazolam
03
Conditions
psychomotor agitation
Beyond the preview
Go deeper on NCT05165914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05165914.